布鲁克拟出售气相/气质、ICP-MS产品线

　　据外媒2014年7月23日消息，布鲁克表示，它不相信其化学与应用市场部门(CAM)可以在未来两年内实现“可接受的财务表现”，它计划出售和或重组部分CAM业务，由此预期裁员200到250人。

　　在提交给美国证券交易委员会(SEC)的一份文件中，布鲁克说，重组计划将导致每年收入减少5000-7000万美元，重组完成后，每年利润预计可以增加1500-2000万元美元。

　　重组CAM部门的决定已由布鲁克董事会于7月18日批准，公司认为保留此业务已不再有意义。2010年，布鲁克在收购了瓦里安部分业务后成立了CAM部门，并且从一开始，CAM就是布鲁克财务的一个权重。在最近的一次投资者会议上，该公司负责人表示，布鲁克将改革该部门。

　　在今天提交给SEC的文件中，布鲁克列出重组CAM计划的细节。它打算剥离或出售CAM的气相产品线及相关服务，包括气相系统和单四极杆气质系统。布鲁克说，至少一些资产的潜在销售正在讨论。

　　此外，布鲁克拟出售或重组CAM的电感耦合等离子体质谱产品线(ICP-MS)及相关服务，并正在对这些资产的潜在销售进行讨论。但是，布鲁克将保留CAM的三重四极杆气质/液质产品线及相关服务，布鲁克认为这部分业务在制药、临床和生命科学研究市场有增长的机会。

　　布鲁克将从第三季度开始实施CAM重组计划，重组预计到2015年6月30日前完成。

　　布鲁克预计在2014下半年及2015年上半年CAM重组及其他一次性费用在3500-4000万美元之间。布鲁克还说，任何CAM相关业务出售的预期收益当前无法计算。

　　2013年，CAM部门的收入约1亿美元。消息公布后，布鲁克股票上涨了近3%，股价24.09美元。 (编译：杨娟)

论坛相关讨论： 布鲁克拟出售气相/气质、ICP-MS产品线，国产厂商是否有意接手? 

附：布鲁克公司关于此事告客户信

Important customer information about ICP-MS, GC and GC-MS products

　　Dear Valued Bruker Customer,

　　After very careful analysis of our served markets and product portfolio, Bruker today announced the decision to reduce its Chemical & Applied Markets (CAM) Division product portfolio. Unfortunately, this decision became inevitable as CAM had generated significant losses for the last 4 years, and with its broad product and market scope there was no way to reach acceptable financial performance for CAM in the foreseeable future.

　　As a result of this decision, effective immediately, Bruker will stop selling its stand-alone GC systems and its single-quadrupole (SQ) GC-SQ mass spectrometry systems. Bruker will deliver and install our existing GC and GC-SQ order backlog, and we will continue to provide service and support for these products and there will be no change in customer service.

　　Bruker has also announced that it is seeking strategic buyers for its GC service business and separately for our ICP-MS business. If these businesses are divested to other global, analytical instrument companies, then further communications will be made to all customers.

　　Bruker will continue to develop, manufacture, sell and service our strategically important and successful EVOQ LC-MS and SCION GC-MS triple-quadruple (TQ) products as part of our Bruker Daltonics mass spectrometry product portfolio.

　　So what will this all mean to you?

　　We will continue to honor our service commitments for the GC and GC-SQ systems. Our GC systems service may be transferred to a potential other major analytical systems company before the end of 2014. We will retain GC-SQ service at Bruker.

　　We will deliver and install our GC and GC-SQ backlog during the second half of 2014, and we accept last-buy orders for GC and GC-SQ during the third quarter of 2014.

　　We will continue to invest vigorously in TQ-MS systems and their applied market applications. Our award-winning SCION GC-TQ and EVOQ LC-TQ systems will be retained by Bruker for sale by our commercial team and our approved distributors.

　　We will keep selling and supporting ICP-MS systems while we transition this business to a potential buyer. We expect to transfer our ICP-MS business to a global, high-quality analytical instruments company with a broader trace elemental analysis portfolio in the next few months.

　　This was a very difficult decision for Bruker and we will work hard with our valued customers to ensure minimization of any inconvenience caused by this decision and announcement.

　　Sincerely,

　　Elmar Illek

　　Senior Vice President

　　Bruker Daltonics Commercial Operations